BASE-CATALYZED-HYDROLYSIS OF 4-HYDROPEROXYCYCLOPHOSPHAMIDE - EVIDENCE FOR IMINOCYCLOPHOSPHAMIDE AS AN INTERMEDIATE

被引:25
作者
BORCH, RF [1 ]
GETMAN, KM [1 ]
机构
[1] UNIV MINNESOTA, DEPT CHEM, MINNEAPOLIS, MN 55455 USA
关键词
D O I
10.1021/jm00370a009
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
cis-4-Hydroperoxycyclophosphamide (5) undergoes facile reaction with aqueous phosphate or Tris buffers at pH 7-8 and 30.degree. C. The kinetics of 5 are complex, and the trans-4-hydroperoxy isomer 6 is produced and subsequently disappears over the course of the reaction. Addition of hydrogen peroxide to the reaction mixture retards the disappearance rate of 5 and increases the amount of 6 generated. Rate constants for the reversible disappearance of 5 and appearance of 6 and 4-hydroxycyclophosphamide (2) have been determined by nonlinear least-squares methods. The reaction is catalyzed by hydroxide ion, Tris free base, and HPO42-, with catalytic constants of 0.032 min-1 (pH 8.0), 0.052 and 0.115 M-1 min-1, respectively. The major product in the presence of Tris is the oxazolidine 8b arising from the addition of Tris to aldophosphamide, not 2 as assumed previously. These results are consistent with a mechanism involving general-base-catalyzed elimination to produce iminocyclophosphamide 7 as a transient intermediate; the imine can react with the hydrogen peroxide evolved in the reaction to give 5 and 6, with water to give 2, or, in general, by addition of a nucleophile to C-4. The significance of these findings with respect to other 4-substituted cyclophosphamides is discussed. [Cyclophosphamide is one of the most widely used and intensively studied agents available for the treatment of malignancy.].
引用
收藏
页码:485 / 490
页数:6
相关论文
共 24 条
[1]   CONFORMATIONS OF SATURATED 6-MEMBERED RING PHOSPHORUS-HETEROCYCLES - CIS-2-OXO-2(DIMETHYLAMINO)-5-TERT-BUTYL-1,3,2-LAMBDA-5-OXAZAPHOSPHORINANES AND TRANS-2-OXO-2(DIMETHYLAMINO)-5-TERT-BUTYL-1,3,2-LAMBDA-5-OXAZAPHOSPHORINANES AND 2-THIO-2-(DIMETHYLAMINO)-5-TERT-BUTYL-1,3,2-LAMBDA-5-OXAZAPHOSPHORINANES - MOLECULES RELATED TO CYCLOPHOSPHAMIDEAM [J].
BAJWA, GS ;
CHANDRASEKARAN, S ;
HARGIS, JH ;
SOPCHIK, AE ;
BLATTER, D ;
BENTRUDE, WG .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1982, 104 (23) :6385-6392
[2]  
BENCKHUYSEN C, 1976, CANCER TREAT REP, V60, P369
[3]  
BORCH RF, J MED CHEM
[4]   ACTIVATED CYCLOPHOSPHAMIDE ANTI-CANCER DRUGS - MOLECULAR-STRUCTURES OF CIS-4-HYDROPEROXYISOPHOSPHAMIDES AND TRANS-4-HYDROPEROXYISOPHOSPHAMIDES [J].
CAMERMAN, A ;
SMITH, HW ;
CAMERMAN, N .
JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (05) :679-683
[5]  
CAMERMAN A, 1976, CANCER TREAT REP, V60, P517
[6]   SOME STUDIES OF ACTIVE INTERMEDIATES FORMED IN MICROSOMAL METABOLISM OF CYCLOPHOSPHAMIDE AND ISOPHOSPHAMIDE [J].
CONNORS, TA ;
COX, PJ ;
FARMER, PB ;
FOSTER, AB ;
JARMAN, M .
BIOCHEMICAL PHARMACOLOGY, 1974, 23 (01) :115-129
[7]  
FEDOR LR, 1970, J AM CHEM SOC, V89, P985
[8]  
FENSELAU C, 1982, DRUG METAB DISPOS, V10, P636
[9]  
FENSELAU C, 1977, CANCER RES, V37, P2538
[10]  
FRIEDMAN O.M., 1979, ADV CANC CHEMOTHERAP, V1, P143